A Phase 1B/2A study to demonstrate the safety and efficacy of CXA-10 in the treatment of Sickle Cell Crisis and Sickle Cell Disease

Trial Profile

A Phase 1B/2A study to demonstrate the safety and efficacy of CXA-10 in the treatment of Sickle Cell Crisis and Sickle Cell Disease

Planning
Phase of Trial: Phase I/II

Latest Information Update: 20 Nov 2015

At a glance

  • Drugs CXA 10 (Primary) ; CXA 10 (Primary)
  • Indications Sickle cell anaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 20 Nov 2015 New trial record
    • 12 Nov 2015 According to Complexa media release, this trial will initiate trials 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top